Literature DB >> 35940589

Two Years into the COVID-19 Pandemic: Lessons Learned.

Severino Jefferson Ribeiro da Silva1,2, Jessica Catarine Frutuoso do Nascimento1, Renata Pessôa Germano Mendes1, Klarissa Miranda Guarines1, Caroline Targino Alves da Silva1, Poliana Gomes da Silva1, Jurandy Júnior Ferraz de Magalhães1,3,4,5, Justin R J Vigar2, Abelardo Silva-Júnior6, Alain Kohl7, Keith Pardee2,8, Lindomar Pena1.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan, China, causing a respiratory disease called coronavirus disease 2019 (COVID-19), which has massively impacted global public health and caused widespread disruption to daily life. The crisis caused by COVID-19 has mobilized scientists and public health authorities across the world to rapidly improve our knowledge about this devastating disease, shedding light on its management and control, and spawned the development of new countermeasures. Here we provide an overview of the state of the art of knowledge gained in the last 2 years about the virus and COVID-19, including its origin and natural reservoir hosts, viral etiology, epidemiology, modes of transmission, clinical manifestations, pathophysiology, diagnosis, treatment, prevention, emerging variants, and vaccines, highlighting important differences from previously known highly pathogenic coronaviruses. We also discuss selected key discoveries from each topic and underline the gaps of knowledge for future investigations.

Entities:  

Keywords:  SARS-CoV-2; clinical features; diagnosis; pathophysiology; prevention; reservoir hosts; transmission; treatment; vaccines; variants

Mesh:

Year:  2022        PMID: 35940589      PMCID: PMC9380879          DOI: 10.1021/acsinfecdis.2c00204

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.578


  658 in total

1.  The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent.

Authors:  Aartjan J W te Velthuis; Jamie J Arnold; Craig E Cameron; Sjoerd H E van den Worm; Eric J Snijder
Journal:  Nucleic Acids Res       Date:  2009-10-29       Impact factor: 16.971

Review 2.  Synthetic Biology Goes Cell-Free.

Authors:  Aidan Tinafar; Katariina Jaenes; Keith Pardee
Journal:  BMC Biol       Date:  2019-08-08       Impact factor: 7.431

3.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

4.  A word of caution in interpreting COVID-19 diagnostics tests.

Authors:  Severino Jefferson Ribeiro da Silva; Lindomar J Pena
Journal:  J Med Virol       Date:  2020-09-19       Impact factor: 2.327

5.  Antibody evasion by the P.1 strain of SARS-CoV-2.

Authors:  Wanwisa Dejnirattisai; Daming Zhou; Piyada Supasa; Chang Liu; Alexander J Mentzer; Helen M Ginn; Yuguang Zhao; Helen M E Duyvesteyn; Aekkachai Tuekprakhon; Rungtiwa Nutalai; Beibei Wang; César López-Camacho; Jose Slon-Campos; Thomas S Walter; Donal Skelly; Sue Ann Costa Clemens; Felipe Gomes Naveca; Valdinete Nascimento; Fernanda Nascimento; Cristiano Fernandes da Costa; Paola Cristina Resende; Alex Pauvolid-Correa; Marilda M Siqueira; Christina Dold; Robert Levin; Tao Dong; Andrew J Pollard; Julian C Knight; Derrick Crook; Teresa Lambe; Elizabeth Clutterbuck; Sagida Bibi; Amy Flaxman; Mustapha Bittaye; Sandra Belij-Rammerstorfer; Sarah C Gilbert; Miles W Carroll; Paul Klenerman; Eleanor Barnes; Susanna J Dunachie; Neil G Paterson; Mark A Williams; David R Hall; Ruben J G Hulswit; Thomas A Bowden; Elizabeth E Fry; Juthathip Mongkolsapaya; Jingshan Ren; David I Stuart; Gavin R Screaton
Journal:  Cell       Date:  2021-03-30       Impact factor: 41.582

6.  Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Authors:  Juanjuan Zhao; Quan Yuan; Haiyan Wang; Wei Liu; Xuejiao Liao; Yingying Su; Xin Wang; Jing Yuan; Tingdong Li; Jinxiu Li; Shen Qian; Congming Hong; Fuxiang Wang; Yingxia Liu; Zhaoqin Wang; Qing He; Zhiyong Li; Bin He; Tianying Zhang; Yang Fu; Shengxiang Ge; Lei Liu; Jun Zhang; Ningshao Xia; Zheng Zhang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

Review 7.  SARS: epidemiology.

Authors:  Moira Chan-Yeung; Rui-Heng Xu
Journal:  Respirology       Date:  2003-11       Impact factor: 6.424

8.  Compositional diversity and evolutionary pattern of coronavirus accessory proteins.

Authors:  Jingzhe Shang; Na Han; Ziyi Chen; Yousong Peng; Liang Li; Hangyu Zhou; Chengyang Ji; Jing Meng; Taijiao Jiang; Aiping Wu
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

9.  Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence.

Authors:  Md Arif Billah; Md Mamun Miah; Md Nuruzzaman Khan
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

10.  β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.

Authors:  Sourish Ghosh; Teegan A Dellibovi-Ragheb; Adeline Kerviel; Eowyn Pak; Qi Qiu; Matthew Fisher; Peter M Takvorian; Christopher Bleck; Victor W Hsu; Anthony R Fehr; Stanley Perlman; Sooraj R Achar; Marco R Straus; Gary R Whittaker; Cornelis A M de Haan; John Kehrl; Grégoire Altan-Bonnet; Nihal Altan-Bonnet
Journal:  Cell       Date:  2020-10-27       Impact factor: 41.582

View more
  1 in total

1.  Use of traditional and complementary medicine for COVID 19 prophylaxis among healthcare professionals and students in Jordan: A cross-sectional study.

Authors:  Nailya Bulatova; Sara Younes; Majd Arabiyat; Ahmad Abukaff; Sara Madanat; Eman Alqudah; Anoud Hamati; Farah Halawa; Abdallah Younes
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.